In order to further disseminate its proprietary barrier technology, on which the new concept “mucoprotection” is based, and as part of its continuous investment in its products´ reputation, Noventure has just participated in this year´s ESPGHAN Congress, held in Prague.
Barcelona, March 13, 2017 - Noventure and Riksförbundet för sexuell upplysning (RFSU), the Swedish Association for Sexuality Education, announce today that they have entered into an agreement by which RFSU will distribute Noventure’s Utipro® Plus in the Nordic countries (Denmark, Finland, Iceland, Norway and Sweden).
European Association of Urology - London 25th - 27th March 2017. More than 10.300 total participants, coming from 113 countries all over the world. Out of around 10.000 delegates, mainly urologists, nearly 20% were residents. 200 exhibitors took part to the congress, thus adding  further 2200 participants to the event.
  A new class of non-drug treatments for rhinitis of various origins is gaining momentum. Among them, Xyloglucan stands out as a natural substance with a well-defined mode of action: its mechanical barrier effect (1) can help in the control of the symptoms of rhinitis by preventing allergens, pathogens and pollutants coming into contact with the nasal mucosa (1, 2).
NOVENTURE will be present at NeuroGastro 2017. Come meet us at our booth number 9 to discover our new product for IBS-D.
As usual Noventure is participating at CPhI Worldwide, this year in Frankfurt. We would like to take this opportunity to hold face to face meetings with you, to discuss current and future opportunities and possible ways of collaboration between our companies.
NOVENTURE will be present at UEG week 2017. Come meet us at our booth (Nº 13) to discover our new product for IBS-D.
Presented at GFHGHP 2012. Presented as oral communication at the 33rd edition of the Congress from the Groupe Francophone d'Hépato-Gastroentérologie et Nutrition Pédiatriques in Nantes, France, March 2012. Abstract: New insights into the mechanism of action of gelatine tannate for acute diarrhoea. Part 1: filmforming effect. Freli V, Moreira da Silva R, Pescio P
Presented at GFHGHP 2012. Presented as oral communication at the 33rd edition of the Congress from the Groupe Francophone d'Hépato-Gastroentérologie et Nutrition Pédiatriques, Nantes (France),March 2012.  Abstract: New insights into the mechanism of action of gelatine tannate for acute diarrhoea. Part 2: antibacterial activity.
UEG Journal - United European Gastroenterology Journal, Oct.2013: Vol. 1, Supl. 1; ISSN 2050-6406 (print) ISSN 2050-6414 (online) - Pags A75-A76  Introduction: